These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. DMG26: A Targeted Sequencing Panel for Mutation Profiling to Address Gaps in the Prognostication of Multiple Myeloma. Cutler SD; Knopf P; Campbell CJV; Thoni A; Abou El Hassan M; Forward N; White D; Wagner J; Goudie M; Boudreau JE; Kennedy BE; Gujar S; Gaston D; Elnenaei MO J Mol Diagn; 2021 Dec; 23(12):1699-1714. PubMed ID: 34562616 [TBL] [Abstract] [Full Text] [Related]
2. Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic leukemia. Gelmez MY; Coskunpinar E; Saracoglu B; Deniz G; Aktan M Immunol Invest; 2017 Jul; 46(5):433-446. PubMed ID: 28388279 [TBL] [Abstract] [Full Text] [Related]
3. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Boyd KD; Ross FM; Chiecchio L; Dagrada GP; Konn ZJ; Tapper WJ; Walker BA; Wardell CP; Gregory WM; Szubert AJ; Bell SE; Child JA; Jackson GH; Davies FE; Morgan GJ; Leukemia; 2012 Feb; 26(2):349-55. PubMed ID: 21836613 [TBL] [Abstract] [Full Text] [Related]
4. Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis. Gutiérrez NC; Castellanos MV; Martín ML; Mateos MV; Hernández JM; Fernández M; Carrera D; Rosiñol L; Ribera JM; Ojanguren JM; Palomera L; Gardella S; Escoda L; Hernández-Boluda JC; Bello JL; de la Rubia J; Lahuerta JJ; San Miguel JF; Leukemia; 2007 Jan; 21(1):143-50. PubMed ID: 17024116 [TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149 [TBL] [Abstract] [Full Text] [Related]
7. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. Pittaluga S; Tierens A; Dodoo YL; Delabie J; De Wolf-Peeters C Am J Clin Pathol; 1999 Feb; 111(2):179-84. PubMed ID: 9930138 [TBL] [Abstract] [Full Text] [Related]
8. Structure of Bcl-1 and igh-CDR3 rearrangements as clonal markers in mantle cell lymphomas. Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510 [TBL] [Abstract] [Full Text] [Related]
9. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes. Linke B; Bolz I; Fayyazi A; von Hofen M; Pott C; Bertram J; Hiddemann W; Kneba M Leukemia; 1997 Jul; 11(7):1055-62. PubMed ID: 9204991 [TBL] [Abstract] [Full Text] [Related]